Oruka Therapeutics (ORKA) Return on Capital Employed Growth (3y) (2014 - 2024)
Oruka Therapeutics (ORKA) Return on Capital Employed Growth (3y) (2014 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Oruka Therapeutics |
3.86 Bn |
3.47 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2024 |
-160.00 |
| Mar 31, 2024 |
-35.00 |
| Dec 31, 2023 |
121.00 |
| Sep 30, 2023 |
101.00 |
| Jun 30, 2023 |
4,328.00 |
| Mar 31, 2023 |
5,645.00 |
| Dec 31, 2022 |
4,521.00 |
| Sep 30, 2022 |
-3,734.00 |
| Jun 30, 2022 |
-3,582.00 |
| Mar 31, 2022 |
-2,635.00 |
| Dec 31, 2021 |
-1,142.00 |
| Sep 30, 2021 |
-5,010.00 |
| Jun 30, 2021 |
-1,296.00 |
| Mar 31, 2021 |
2,108.00 |
| Dec 31, 2020 |
2,953.00 |
| Sep 30, 2020 |
10,890.00 |
| Jun 30, 2020 |
5,238.00 |
| Mar 31, 2020 |
773.00 |
| Dec 31, 2019 |
-142.00 |
| Sep 30, 2019 |
5,868.00 |
